With the United Nations set to meet on the urgency of diseases, brand-name drug makers and the Obama administration are fighting potential sales of cheaper medicines to poorer countries. The Obama administration has been trying to stop an effort by poorer nations to strike a new international bargain that would allow them to get around patent rights and import cheaper Indian and Chinese knock-off drugs for cancer and other diseases, as they did to fight AIDS. The debate turns on whether diseases like cancer can be characterized as emergencies, or “epidemics.”. “We would love to have better access to better drugs,” Dr. Mohar,general director of the Mexican National Cancer Institute, said. “This debate is going to heat up.”
No comments:
Post a Comment